Okusaka T - Search Results

1

Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.

Okita K, Izumi N, Matsui O, Tanaka K, Kaneko S, Moriwaki H, Ikeda K, Osaki Y, Numata K, Nakachi K, Kokudo N, Imanaka K, Nishiguchi S, Okusaka T, Nishigaki Y, Shiomi S, Kudo M, Ido K, Karino Y, Hayashi N, Ohashi Y, Makuuchi M, Kumada H; Peretinoin Study Group. Okita K, et al. Among authors: okusaka t. J Gastroenterol. 2015 Feb;50(2):191-202. doi: 10.1007/s00535-014-0956-9. Epub 2014 Apr 13. J Gastroenterol. 2015. PMID: 24728665 Free PMC article. Clinical Trial.

2

A phase II study of cisplatin in patients with biliary tract carcinoma.

Okada S, Ishii H, Nose H, Yoshimori M, Okusaka T, Aoki K, Iwasaki M, Furuse J, Yoshino M. Okada S, et al. Among authors: okusaka t. Oncology. 1994 Nov-Dec;51(6):515-7. doi: 10.1159/000227396. Oncology. 1994. PMID: 7970496 Clinical Trial.

3

Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.

Ishii H, Okada S, Sato T, Nose H, Okusaka T, Yoshimori M, Takayasu K, Takayama T, Kosuge T, Yamasaki S. Ishii H, et al. Among authors: okusaka t. Hepatogastroenterology. 1996 May-Jun;43(9):644-50. Hepatogastroenterology. 1996. PMID: 8799409

4

The prognosis of patients with hepatocellular carcinoma of multicentric origin.

Okusaka T, Okada S, Nose H, Ishii H, Nakasuka H, Nakayama H, Nagahama H, Yoshimori M, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Okusaka T, et al. Hepatogastroenterology. 1996 Jul-Aug;43(10):919-25. Hepatogastroenterology. 1996. PMID: 8884314

5

Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.

Ishii H, Okada S, Nose H, Okusaka T, Nagahama H, Nakayama H, Nakasuka H, Yoshimori M. Ishii H, et al. Among authors: okusaka t. Hepatogastroenterology. 1996 Jul-Aug;43(10):938-43. Hepatogastroenterology. 1996. PMID: 8884317

6

Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.

Okusaka T, Okada S, Ishii H, Nose H, Nagahama H, Nakasuka H, Ikeda K, Yoshimori M. Okusaka T, et al. Hepatogastroenterology. 1997 Jan-Feb;44(13):251-7. Hepatogastroenterology. 1997. PMID: 9058154

7

Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer.

Okusaka T, Okada S, Sato T, Wakasugi H, Saisho H, Furuse J, Ishikawa O, Matsuno S, Yokoyama S. Okusaka T, et al. Hepatogastroenterology. 1998 May-Jun;45(21):867-72. Hepatogastroenterology. 1998. PMID: 9684148

8

5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.

Nose H, Okada S, Okusaka T, Furuse J, Yoshino M, Ogoshi K, Kato T, Miyaji M, Hoshino M, Ariyama J, Suyama M, Karasawa E, Yoshimori M. Nose H, et al. Among authors: okusaka t. Hepatogastroenterology. 1999 Nov-Dec;46(30):3244-8. Hepatogastroenterology. 1999. PMID: 10626195 Clinical Trial.

9

Phase I trial of gemcitabine in patients with advanced pancreatic cancer.

Okada S, Ueno H, Okusaka T, Ikeda M, Furuse J, Maru Y. Okada S, et al. Among authors: okusaka t. Jpn J Clin Oncol. 2001 Jan;31(1):7-12. doi: 10.1093/jjco/hye003. Jpn J Clin Oncol. 2001. PMID: 11256843 Clinical Trial.

10

Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.

Ueno H, Okada S, Okusaka T, Ikeda M, Tanaka N, Sakamoto M, Yoshimori M. Ueno H, et al. Among authors: okusaka t. Hepatogastroenterology. 2001 Sep-Oct;48(41):1430-4. Hepatogastroenterology. 2001. PMID: 11677980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters